Literature DB >> 26304506

Distinctive expression pattern of interleukin-17 cytokine family members in colorectal cancer.

Ahmed Al-Samadi1,2, Shirin Moossavi3, Abdelhakim Salem1, Masoud Sotoudeh4, Sarianna M Tuovinen1, Yrjö T Konttinen1,5,6, Tuula Salo2, Faraz Bishehsari7.   

Abstract

Colorectal cancer (CRC) is one of the most common cancers in both genders. Even though interleukin (IL)-17A was shown to play an important role in intestinal tumourigenesis and CRC, other IL-17 family members were not studied well. We therefore studied the expression of IL-17 cytokine family members in CRC. Ten healthy colons and ten CRC mucosa were immunostained for IL-17B, IL-17C, IL-17E, and IL-17F, and their receptors IL-17RA, IL-17RB, and IL-17RC. Double immunofluorescence staining of the CRC mucosa was done for IL-17B with markers of neutrophils, endothelial cells, macrophages, T cells, mast cells, or fibroblasts. While IL-17B was increased in CRC with a strong presence both in the epithelial and stromal compartments, IL-17C showed different expression depending on the grade of differentiation and IL-17E remained unchanged. In contrast, IL-17F was decreased in CRC compared to healthy control. Colon epithelial cells stained positive for IL-17RA, IL-17RB, and IL-17RC in both healthy control and CRC. Neutrophils were the main source of IL-17B in the stroma. IL-17 family members demonstrated distinct expression patterns in CRC, suggesting a differential role exerted by each member in colon carcinogenesis.

Entities:  

Keywords:  Colorectal cancer; IL-17; IL-17B; Neutrophil

Mesh:

Substances:

Year:  2015        PMID: 26304506     DOI: 10.1007/s13277-015-3941-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

Review 1.  The IL-17 family cytokines in immunity and disease.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Naruhisa Ota; Wenjun Ouyang; Yan Hu
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

Review 2.  The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Arivazhagan Sambandam
Journal:  Immunology       Date:  2011-07-04       Impact factor: 7.397

3.  Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis.

Authors:  Xinyang Song; Hanchao Gao; Yingying Lin; Yikun Yao; Shu Zhu; Jingjing Wang; Yan Liu; Xiaomin Yao; Guangxun Meng; Nan Shen; Yufang Shi; Yoichiro Iwakura; Youcun Qian
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

4.  Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis.

Authors:  Yufeng Xie; Weihua Sheng; Jim Xiang; Zhenmin Ye; Jicheng Yang
Journal:  Cancer Invest       Date:  2010-07       Impact factor: 2.176

5.  Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.

Authors:  Wook-Jin Chae; Thomas F Gibson; Daniel Zelterman; Liming Hao; Octavian Henegariu; Alfred L M Bothwell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

Review 6.  Neutrophil-derived cytokines involved in physiological and pathological angiogenesis.

Authors:  Cristina Tecchio; Marco Antonio Cassatella
Journal:  Chem Immunol Allergy       Date:  2013-10-17

7.  Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.

Authors:  Roberta Caruso; Massimiliano Sarra; Carmine Stolfi; Angelamaria Rizzo; Daniele Fina; Massimo Claudio Fantini; Francesco Pallone; Thomas T MacDonald; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2009-06       Impact factor: 22.682

8.  Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.

Authors:  Ana Camelo; Jillian L Barlow; Lesley F Drynan; Daniel R Neill; Sarah J Ballantyne; See Heng Wong; Richard Pannell; Wei Gao; Keely Wrigley; Justin Sprenkle; Andrew N J McKenzie
Journal:  J Gastroenterol       Date:  2012-04-27       Impact factor: 7.527

9.  The changes of Th17 cells and the related cytokines in the progression of human colorectal cancers.

Authors:  Jiansheng Wang; Kaiyu Xu; Jing Wu; Chenghua Luo; Yuchen Li; Xuebin Wu; Hong Gao; Guosheng Feng; Bao-Zhu Yuan
Journal:  BMC Cancer       Date:  2012-09-21       Impact factor: 4.430

10.  Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.

Authors:  Keiji Hayata; Makoto Iwahashi; Toshiyasu Ojima; Masahiro Katsuda; Takeshi Iida; Mikihito Nakamori; Kentaro Ueda; Masaki Nakamura; Motoki Miyazawa; Toshiaki Tsuji; Hiroki Yamaue
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more
  13 in total

Review 1.  Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type.

Authors:  Joseph Fabre; Jerome Giustiniani; Christian Garbar; Frank Antonicelli; Yacine Merrouche; Armand Bensussan; Martine Bagot; Reem Al-Dacak
Journal:  Int J Mol Sci       Date:  2016-08-30       Impact factor: 5.923

2.  Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions.

Authors:  Eman Taha Ali; Mai Abdulrahman Mohammed Masri; Emmanuel Edwar Siddig; Ayman Ahmed; Mohamed S Muneer; Nouh Saad Mohamed; Ali Mahmoud Mohammed Edris
Journal:  BMC Res Notes       Date:  2020-06-23

3.  Variable roles of interleukin-17F in different cancers.

Authors:  Tiina Mikkola; Rabeia Almahmoudi; Tuula Salo; Ahmed Al-Samadi
Journal:  BMC Cancer       Date:  2022-01-11       Impact factor: 4.430

Review 4.  Cytokine-Induced Modulation of Colorectal Cancer.

Authors:  Lukas F Mager; Marie-Hélène Wasmer; Tilman T Rau; Philippe Krebs
Journal:  Front Oncol       Date:  2016-04-19       Impact factor: 6.244

5.  A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It.

Authors:  Nicola Tamassia; Fabio Arruda-Silva; Federica Calzetti; Silvia Lonardi; Sara Gasperini; Elisa Gardiman; Francisco Bianchetto-Aguilera; Luisa Benerini Gatta; Giampiero Girolomoni; Alberto Mantovani; William Vermi; Marco A Cassatella
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

6.  Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer.

Authors:  Tsvetelina Veselinova Velikova; Lyuba Miteva; Noyko Stanilov; Zoya Spassova; Spaska Angelova Stanilova
Journal:  World J Gastroenterol       Date:  2020-04-28       Impact factor: 5.742

Review 7.  The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer.

Authors:  Jérémy Bastid; Cécile Dejou; Aurélie Docquier; Nathalie Bonnefoy
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561

Review 8.  Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?

Authors:  Nicola Tumino; Paola Vacca; Linda Quatrini; Enrico Munari; Francesca Moretta; Andrea Pelosi; Francesca Romana Mariotti; Lorenzo Moretta
Journal:  Front Immunol       Date:  2020-01-29       Impact factor: 7.561

Review 9.  Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer.

Authors:  Arianna Brevi; Laura Lucia Cogrossi; Giulia Grazia; Desirée Masciovecchio; Daniela Impellizzieri; Lucrezia Lacanfora; Matteo Grioni; Matteo Bellone
Journal:  Front Immunol       Date:  2020-11-10       Impact factor: 7.561

Review 10.  Interleukin-25: New perspective and state-of-the-art in cancer prognosis and treatment approaches.

Authors:  Arezoo Gowhari Shabgah; Azwar Amir; Zhanna R Gardanova; Angelina Olegovna Zekiy; Lakshmi Thangavelu; Maryam Ebrahimi Nik; Majid Ahmadi; Jamshid Gholizadeh Navashenaq
Journal:  Cancer Med       Date:  2021-06-15       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.